Advertisement
Advertisement
Onetazid

Onetazid

ceftazidime

Manufacturer:

Brawn Labs

Distributor:

One Pharma
Concise Prescribing Info
Contents
Ceftazidime
Indications/Uses
Infections caused by susceptible Pseudomonas aeruginosa & aerobic gram +ve organisms, including lower resp tract, skin, soft tissue, abdominal, bone & joints infection, UTI.
Dosage/Direction for Use
Intermittent IV/IM Adult & childn ≥40 kg Broncho-pulmonary infection in cystic fibrosis 100-150 mg/kg/day every 8 hr. Max daily dose: 9 g. Febrile neutropenia, nosocomial pneumonia, bacterial meningitis, bacteraemia 2 g every 8 hr. Bone & joint infection, complicated skin & soft tissue infection, complicated intra-abdominal infection, peritonitis associated w/ dialysis in patient on CAPD, chronic suppurative otitis media, malignant otitis externa 1-2 g every 8 hr. Complicated UTI 1-2 g every 8 hr or 12 hr. Pre-op prophylaxis for transurethral resection of prostate (TURP) 1 g at induction of anaesth, & 2nd dose at catheter removal. Infant, toddler >2 mth & childn <40 kg Complicated UTI, chronic suppurative otitis media, malignant otitis externa, bone & joint infection, complicated skin & soft tissue infection, complicated intra-abdominal infection & peritonitis associated w/ dialysis in patient on CAPD 100-150 mg/kg/day in 3 divided doses. Max daily dose: 6 g. Neutropenia, broncho-pulmonary infection in cystic fibrosis, bacterial meningitis, bacteraemia 150 mg/kg/day in 3 divided doses. Max daily dose: 6 g. Neonate & infant ≤2 mth 25-60 mg/kg/day in 2 divided doses in most infections. Continuous infusion Febrile neutropenia, nosocomial pneumonia, broncho-pulmonary infection in cystic fibrosis, bacterial meningitis, bacteraemia, bone & joint infection, complicated skin & soft tissue infection, complicated intra-abdominal infection, peritonitis associated w/ dialysis in patient on CAPD Adult & childn ≥40 kg Loading dose: 2 g followed by 4-6 g continuous infusion every 24 hr. Infant, toddler >2 mth & childn <40 kg Loading dose: 60-100 mg/kg followed by a continuous infusion 100-200 mg/kg/day. Max daily dose: 6 g.
Contraindications
Hypersensitivity to penicillin or cephalosporins.
Special Precautions
Hypersensitivity to penicillins & β-lactams. Personal or familial history of allergy eg, bronchial asthma, rash or urticaria. Patients w/ severe renal impairment, malnutrition & those w/ general condition. Discontinue immediately if severe allergic reaction occurs. Reports of antibacterial agent-associated colitis & pseudomembranous colitis. Prolonged use may result in overgrowth of non-susceptible organisms (eg, Enterococci, fungi). Concurrent treatment w/ high dose cephalosporin & nephrotoxic medicinal products eg, aminoglycosides or potent diuretics (eg, furosemide) may adversely affect renal function. Should only be used in pregnant woman if clearly needed. Caution when administered to a nursing woman. Decrease dose in elderly w/ renal impairment.
Adverse Reactions
Diarrhea, abdominal pain, vomiting, nausea; rash, urticaria, pruritus, SJS; shock; slight increase in SGOT, SGPT, alkaline phosphatase; slight increase in serum creatinine; headache, dizziness; leukopenia, thrombocytopenia, eosinophilia; candidiasis, vaginitis.
Drug Interactions
Risk of nephrotoxicity w/ aminoglycosides or diuretic. Antagonism w/ chloramphenicol.
MIMS Class
Cephalosporins
ATC Classification
J01DD02 - ceftazidime ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Onetazid powd for inj 1 g
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement